1. "2011"
  2. "American Society of Hematology"
Formats
  1. Meeting Abstract (108)
  2. Journal Article (40)
Groups
  1. Department of Medicine (110)
  2. Hematologic Malignancies, Division of (107)
  3. Center for Hematologic Malignancies (104)
  4. GSK Faculty (54)
  5. Adult Leukemia (42)
  6. Sloan Kettering Institute Faculty (38)

More Groups

People
  1. Ross Levine (19)
  2. Sergio Giralt (18)
  3. Martin Tallman (14)
  4. Stephen Nimer (12)
  5. Omar Abdel-Wahab (11)
  6. Marcel Van Den Brink (10)

More People

Years
  1. 2011 (148)
Publications
  1. Blood (147)
  2. Hematology-American Society of Hematology Education Program (1)
Publishers
  1. American Society of Hematology (148)

Results (148)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FLT3-ITD+ AML blast, progenitor and stem cell populations demonstrate higher sensitivity to the HSP90 inhibitor PU-H71
    Meeting Abstract

    Zong, H. L.; Taldone, T.; Ahn, J. H.; Brennan, S.; De Leon, J. P.; Becker, M. W.; Roboz, G. J.; Chiosis, G.; Guzman, M. L.
    Blood (2011)

    Fulltext@MSK | Save
  • Methylation of RUNX1 by the nuclear PRMT5/COPR5 complex regulates its cellular location in leukemia cells
    Meeting Abstract

    Zhao, X. Y.; Vu, L. P.; Perna, F.; Liu, F.; Xu, H.; Nimer, S.
    Blood (2011)

    Fulltext@MSK | Save
  • Baseline staging evaluation in lymphoma: The role of FDG PET, CT, and bone marrow biopsy
    Meeting Abstract

    Zelenetz, A. D.; Maragulia, J.; Horwitz, S. M.
    Blood (2011)

    Fulltext@MSK | Save
  • Patterns of disease relapse and progression in patients with multiple myeloma after first line therapy with autologous stem cell transplantation: Implications for patient monitoring after transplantation
    Meeting Abstract

    Zamarin, D.; Bhutani, M.; Chimento, D.; Giralt, S.; Lendvai, N.; Landau, H.; Lesokhin, A.; Chung, D.; Babu, D.; Hassoun, H.
    Blood (2011)

    Fulltext@MSK | Save
  • Loss of p53 accelerates the complications of myelodysplastic syndromes (MDS) in the NUP98-HOXD13 transgenic mouse model
    Meeting Abstract

    Xu, H. M.; Menendez, S.; Deblasio, T. R.; Aplan, P.; Nimer, S.
    Blood (2011)

    Fulltext@MSK | Save
  • Impact of age on outcomes following initial therapy with various chemotherapy and chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia (CLL): Results of CALGB studies
    Meeting Abstract

    Woyach, J. A.; Ruppert, A. S.; Peterson, B.; Rai, K. R.; Lin, T. S.; Appelbaum, F. R.; Tallman, M. S.; Belch, A. R.; Larson, R. A.; Byrd, J. C.
    Blood (2011)

    Fulltext@MSK | Save
  • Elderly Hodgkin lymphoma At MSKCC From 1994-2008: Characteristics, outcome and risk factor analysis in 133 patients
    Meeting Abstract

    Word, Z. H.; Maragulia, J. C.; Walkley, J.; Smith, D. R.; Hamlin, P.
    Blood (2011)

    Fulltext@MSK | Save
  • Induction of megakaryocyte polyploidization in combination with JAK inhibition as a novel therapeutic strategy for myeloproliferative neoplasms
    Meeting Abstract

    Wen, Q. J.; Goldenson, B.; Malinge, S.; Koppikar, P.; Levine, R. L.; Tefferi, A.; Crispino, J.
    Blood (2011)

    Fulltext@MSK | Save
  • HSP90 inhibition targets JAK2 and is highly effective in CRLF2-rearranged acute lymphoblastic leukemia
    Meeting Abstract

    Weigert, O.; Bird, L.; Kopp, N.; Lane, A. A.; Chapuy, B.; van Bodegom, D.; Marubayashi, S.; Yoda, A.; Romanet, V.; Murakami, M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Anti-CD22 immunoconjugate inotuzumab ozogamicin plus rituximab followed by stem cell transplantation in relapsed/refractory DLBCL patients: Safety and efficacy
    Meeting Abstract

    Wagner-Johnston, N.; Goy, A.; Rodriguez, M. A.; Ehmann, C.; Hamlin, P.; Radford, J.; Thieblemont, C.; Suh, C.; Sweetenham, J.; Jiang, Y.; more...
    Blood (2011)

    Fulltext@MSK | Save